Efficacy of Fulvestrant in Women with Hormone-Resistant Metastatic Breast Cancer (mBC): A Canadian Province Experience
Samitha Andrahennadi(University of Saskatchewan), Shahid Ahmed(Emory University), Ali El‐Gayed, Haji Chalchal, Mita Manna(Saskatchewan Cancer Agency), Philip Wright(University of Saskatchewan), Osama Ahmed(University of Saskatchewan), Amer Sami(University of Saskatchewan), Kamal Haider(University of Saskatchewan), Duc Le(University of Saskatchewan)
Cited by 7
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial
|Journal of Clinical Oncology|2013|261
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183